Keeping You Updated
PharmaVentures acts as exclusive advisor to sanofi-aventis in landmark divestment deal with Covance
Oxford, UK. 01 October 2010: PharmaVentures are pleased to announce that they acted as transaction advisors and sale process executioners for sanofi-aventis in their strategic deal with Covance. Under the terms of the agreement, sanofi-aventis will retain access to some of the capabilities which have been divested to Covance as part of a long-term strategic alliance. Covance will provide sanofi-aventis with a 10-year sole source relationship for central lab services.
PharmaVentures has built considerable experience in the M&A field including divestments of manufacturing and R&D businesses. Fintan Walton, CEO, PharmaVentures Ltd said: “The pharmaceutical industry is undergoing a significant transformation with more complex deal structures. The engagement with sanofi-aventis capitalized on PharmaVentures vast experience in complex strategic partnerships and deal transactions”.
Over the past 19 years, PharmaVentures has acted as advisor to over 600 global pharmaceutical and biotechnology clients in transactions covering licensing, merger, acquisition, divestment and joint venture activities for companies.
For press enquiries, please contact:
Dr Fintan Walton, CEO
PharmaVentures
+44 (0) 1865 332700
- ends -
About PharmaVentures
PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances. Our unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes us uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.
Find out more www.pharmaventures.com
Our services include:
- M&A (divestments, mergers, acquisitions and strategic transactions)
- Strategy (commercialisation, deal strategy, due diligence, market entry)
- Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
- Licensing (in and out licensing)
- Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
Now in its 21st year, PharmaVentures is based in Oxford, UK, and employs over 17 people.
For further information, contact:
Dr Fintan Walton
CEO
PharmaVentures Ltd
+44 1865 332700
enquiries@pharmaventures.com